Rejuvenation Dermatology’s Clinical Trials Department is a national, multi-site research network dedicated to advancing dermatologic care through ethically conducted, regulated clinical research. Integrated within routine clinical practice, the department partners with global pharmaceutical sponsors to evaluate novel therapies and offers early access to innovative treatment options. The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators, and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today, it operates with standardized infrastructure, centralized oversight, and experienced investigators across Canada.
Our clinical research team consists of experienced coordinators, nurses, research professionals, and operational staff dedicated to advancing dermatologic research across a wide range of skin conditions. With diverse backgrounds in healthcare, clinical operations, laboratory science, epidemiology, and patient care, the team brings a collaborative and patient-centered approach to every study.
Our clinical research team consists of experienced coordinators, nurses, research professionals, and operational staff dedicated to advancing dermatologic research across a wide range of skin conditions. With diverse backgrounds in healthcare, clinical operations, laboratory science, epidemiology, and patient care, the team brings a collaborative and patient-centered approach to every study.
Rejuvenation Dermatology operates as a national clinical trials network embedded within everyday patient care. By integrating research directly into clinical practice, we are able to evaluate new therapies in real-world settings while maintaining the highest medical standards. This approach allows patients to access innovative treatments earlier, while generating meaningful data that reflects how therapies perform outside of controlled environments.
What began as a single research-focused clinic has evolved into a coordinated, multi-site network across Canada. With standardized infrastructure, centralized oversight, and experienced investigators at every location, we deliver consistent execution across all studies. This structure enables efficient study activation, scalable recruitment, and reliable outcomes for both patients and sponsors.
Our work is grounded in evidence-based medicine. Every clinical trial we conduct contributes to the development of safer, more effective dermatologic treatments. By participating in regulated research, we help shape the future of patient care—ensuring that new therapies are supported by rigorous scientific validation before reaching the broader population.
Clinical research is how innovation reaches patients. Through our trials, participants gain access to investigational therapies that are not yet commercially available. At the same time, our physicians remain at the forefront of dermatologic advancements, continuously applying the latest knowledge to improve patient outcomes.
Patient safety is built into every stage of our research process. All studies undergo independent ethics review before initiation, and participants are carefully screened using strict eligibility criteria. Throughout each trial, patients are closely monitored by experienced physicians and research staff, with every outcome documented and managed in accordance with regulatory standards.
High-quality research depends on reliable data. Our studies are conducted within secure, compliant systems that protect patient information and ensure audit readiness. Through close collaboration with sponsors, CROs, and ethics boards, we deliver accurate, consistent data that supports regulatory approval and advances dermatologic innovation.
Rejuvenation Dermatology delivers clinical research grounded in experience, consistency, and rigorous oversight. Our multi-site network is supported by dedicated investigators and specialized research teams who follow standardized protocols to ensure accuracy, patient safety, and regulatory compliance. With a strong track record across a wide range of studies, we provide reliable execution and high-quality data that sponsors and patients can trust.
CLINICAL TRIALS | CLINICAL TRIALS CANADA | REJUVENATION DERMATOLOGY
Rejuvenation Dermatology’s Clinical Trials Department is a national, multi-site research network dedicated to advancing dermatologic care through ethically conducted, regulated clinical research. Integrated within routine clinical practice, the department partners with global pharmaceutical sponsors to evaluate novel therapies and offers early access to innovative treatment options. The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators, and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today, it operates with standardized infrastructure, centralized oversight, and experienced investigators across Canada.
